First Header Logo Second Header Logo

Connection

Sanjay Gandhi to Treatment Outcome

This is a "connection" page, showing publications Sanjay Gandhi has written about Treatment Outcome.
Connection Strength

1.085
  1. Coutinho AD, Gandhi K, Fuldeore RM, Landsman-Blumberg PB, Gandhi S. Long-term opioid users with chronic noncancer pain: Assessment of opioid abuse risk and relationship with healthcare resource use. J Opioid Manag. 2018 Mar/Apr; 14(2):131-141.
    View in: PubMed
    Score: 0.093
  2. Pasala T, Hoo JS, Lockhart MK, Waheed R, Sengodan P, Alexander J, Gandhi S. Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease. Tex Heart Inst J. 2016 Dec; 43(6):482-487.
    View in: PubMed
    Score: 0.085
  3. Athappan G, Sengodan P, Chacko P, Gandhi S. Comparative efficacy of different modalities for treatment of right heart thrombi in transit: a pooled analysis. Vasc Med. 2015 Apr; 20(2):131-8.
    View in: PubMed
    Score: 0.076
  4. Malhotra A, Garg P, Bishnoi AK, Pendro V, Sharma P, Upadhyay M, Gandhi S. Is steel wire closure of sternotomy better than polyester suture closure? Asian Cardiovasc Thorac Ann. 2014 May; 22(4):409-15.
    View in: PubMed
    Score: 0.071
  5. Rana H, Parikh P, Shah AN, Gandhi S. Epidemiology and clinical outcome of H1N1 in Gujarat from July 2009 to March 2010. J Assoc Physicians India. 2012 Feb; 60:95-7.
    View in: PubMed
    Score: 0.061
  6. Gandhi S, Weinberg I, Margey R, Jaff MR. Comprehensive medical management of peripheral arterial disease. Prog Cardiovasc Dis. 2011 Jul-Aug; 54(1):2-13.
    View in: PubMed
    Score: 0.058
  7. Gandhi SK, Järbrink K, Fox KM, Brandrup-Wognsen G. Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice. Curr Med Res Opin. 2009 Dec; 25(12):2817-28.
    View in: PubMed
    Score: 0.052
  8. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC. "Off-label" stent therapy 2-year comparison of drug-eluting versus bare-metal stents. J Am Coll Cardiol. 2008 Feb 12; 51(6):607-14.
    View in: PubMed
    Score: 0.046
  9. Applegate RJ, Sacrinty M, Kutcher MA, Gandhi SK, Baki TT, Santos RM, Little WC. Vascular complications with newer generations of angioseal vascular closure devices. J Interv Cardiol. 2006 Feb; 19(1):67-74.
    View in: PubMed
    Score: 0.040
  10. Gandhi S, Abramov Y, Kwon C, Beaumont JL, Botros S, Sand PK, Goldberg RP. TVT versus SPARC: comparison of outcomes for two midurethral tape procedures. Int Urogynecol J Pelvic Floor Dysfunct. 2006 Feb; 17(2):125-30.
    View in: PubMed
    Score: 0.039
  11. Gandhi S, Goldberg RP, Kwon C, Koduri S, Beaumont JL, Abramov Y, Sand PK. A prospective randomized trial using solvent dehydrated fascia lata for the prevention of recurrent anterior vaginal wall prolapse. Am J Obstet Gynecol. 2005 May; 192(5):1649-54.
    View in: PubMed
    Score: 0.038
  12. Gandhi S, Beaumont JL, Goldberg RP, Kwon C, Abramov Y, Sand PK. Foley versus intermittent self-catheterization after transvaginal sling surgery: which works best? Urology. 2004 Jul; 64(1):53-7.
    View in: PubMed
    Score: 0.036
  13. Choi CH, Cheng V, Malaver D, Kon N, Kincaid EH, Gandhi SK, Applegate RJ, Zhao DXM. A comparison of valve-in-valve transcatheter aortic valve replacement in failed stentless versus stented surgical bioprosthetic aortic valves. Catheter Cardiovasc Interv. 2019 05 01; 93(6):1106-1115.
    View in: PubMed
    Score: 0.025
  14. Gilbert ON, Choi CH, Franzil JL, Caughey M, Qureshi W, Stacey RB, Pu M, Applegate RJ, Gandhi SK, Zhao DXM. Comparison of paravalvular aortic leak characteristics in the Medtronic CoreValve versus Edwards Sapien Valve: Paravalvular aortic leak characteristics. Catheter Cardiovasc Interv. 2018 11 01; 92(5):972-980.
    View in: PubMed
    Score: 0.023
  15. Drafts BC, Choi CH, Sangal K, Cammarata MW, Applegate RJ, Gandhi SK, Kincaid EH, Kon N, Zhao DX. Comparison of outcomes with surgical cut-down versus percutaneous transfemoral transcatheter aortic valve replacement: TAVR transfemoral access comparisons between surgical cut-down and percutaneous approach. Catheter Cardiovasc Interv. 2018 06; 91(7):1354-1362.
    View in: PubMed
    Score: 0.023
  16. McGarry A, Kieburtz K, Abler V, Grachev ID, Gandhi S, Auinger P, Papapetropoulos S, Hayden M. Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease. J Huntingtons Dis. 2017; 6(3):189-199.
    View in: PubMed
    Score: 0.021
  17. Sharma P, Malhotra A, Gandhi S, Garg P, Bishnoi A, Gandhi H. Preoperative levosimendan in ischemic mitral valve repair. Asian Cardiovasc Thorac Ann. 2014 Jun; 22(5):539-45.
    View in: PubMed
    Score: 0.017
  18. Applegate R, Sacrinty M, Schafer P, Smith J, Gandhi S, Kutcher M, Santos R, Cecile A, Little W. Cost effectiveness of radial access for diagnostic cardiac catheterization and coronary intervention. Catheter Cardiovasc Interv. 2013 Oct 01; 82(4):E375-84.
    View in: PubMed
    Score: 0.016
  19. Riley RF, Newby LK, Don CW, Roe MT, Holmes DN, Gandhi SK, Kutcher MA, Herrington DM. Diagnostic time course, treatment, and in-hospital outcomes for patients with ST-segment elevation myocardial infarction presenting with nondiagnostic initial electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Am Heart J. 2013 Jan; 165(1):50-6.
    View in: PubMed
    Score: 0.016
  20. Turner S, Sacrinty M, Manogue M, Little W, Gandhi S, Kutcher M, Santos R, Applegate R. Transitioning to the radial artery as the preferred access site for cardiac catheterization: an academic medical center experience. Catheter Cardiovasc Interv. 2012 Aug 01; 80(2):247-57.
    View in: PubMed
    Score: 0.015
  21. Penn MS, Ellis S, Gandhi S, Greenbaum A, Hodes Z, Mendelsohn FO, Strasser D, Ting AE, Sherman W. Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circ Res. 2012 Jan 20; 110(2):304-11.
    View in: PubMed
    Score: 0.015
  22. Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC. Target lesion revascularization after bare-metal or drug-eluting stents: clinical presentations and outcomes. J Invasive Cardiol. 2010 Jun; 22(6):266-70.
    View in: PubMed
    Score: 0.014
  23. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. 3-year comparison of drug-eluting versus bare-metal stents. JACC Cardiovasc Interv. 2009 Mar; 2(3):231-9.
    View in: PubMed
    Score: 0.012
  24. Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC. Effect of length and diameter of drug-eluting stents versus bare-metal stents on late outcomes. Circ Cardiovasc Interv. 2009 Feb; 2(1):35-42.
    View in: PubMed
    Score: 0.012
  25. Applegate RJ, Graham SH, Gandhi SK, Kutcher MA, Sacrinty MT, Santos RM, Little WC. Culprit vessel PCI versus traditional cath and PCI for STEMI. J Invasive Cardiol. 2008 May; 20(5):224-8.
    View in: PubMed
    Score: 0.012
  26. Harley CR, Gandhi SK, Heien H, McDonough K, Nelson SP. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother. 2008 Apr; 9(5):669-76.
    View in: PubMed
    Score: 0.012
  27. Fox KM, Gandhi SK, Ohsfeldt RL, Davidson MH. Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. Am J Manag Care. 2007 Dec; 13 Suppl 10:S270-5.
    View in: PubMed
    Score: 0.011
  28. Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Davidson MH. Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. Clin Ther. 2007 Nov; 29(11):2385-94.
    View in: PubMed
    Score: 0.011
  29. Fox KM, Gandhi SK, Ohsfeldt RL, Blasetto JW, Bays HE. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Curr Med Res Opin. 2007 Sep; 23(9):2125-33.
    View in: PubMed
    Score: 0.011
  30. Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Am J Geriatr Pharmacother. 2007 Sep; 5(3):185-94.
    View in: PubMed
    Score: 0.011
  31. Bullano MF, Kamat S, Wertz DA, Borok GM, Gandhi SK, McDonough KL, Willey VJ. Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting. Am J Health Syst Pharm. 2007 Feb 01; 64(3):276-84.
    View in: PubMed
    Score: 0.011
  32. Botros SM, Miller JJ, Goldberg RP, Gandhi S, Akl M, Beaumont JL, Sand PK. Detrusor overactivity and urge urinary incontinence following trans obturator versus midurethral slings. Neurourol Urodyn. 2007; 26(1):42-5.
    View in: PubMed
    Score: 0.011
  33. Applegate RJ, Grabarczyk MA, Sane DC, Sacrinty MT, Goodin JE, Statonk GS, Baki TT, Gandhi SK, Kutcher MA, Little WC. PCI with and without abciximab after upstream eptifibatide use: outcomes in high-risk patients. J Invasive Cardiol. 2006 Dec; 18(12):604-13.
    View in: PubMed
    Score: 0.011
  34. Ohsfeldt RL, Gandhi SK, Fox KM, Stacy TA, McKenney JM. Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. Am J Manag Care. 2006 Nov; 12(15 Suppl):S412-23.
    View in: PubMed
    Score: 0.011
  35. Bullano MF, Wertz DA, Yang GW, Kamat S, Borok GM, Gandhi S, McDonough KL, Willey VJ. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting. Pharmacotherapy. 2006 Apr; 26(4):469-78.
    View in: PubMed
    Score: 0.010
  36. Botros SM, Abramov Y, Goldberg RP, Beaumont JL, Gandhi S, Miller JJ, Sand PK. Detrusor overactivity and urge urinary incontinence [corrected] following midurethral versus bladder sling procedures. Am J Obstet Gynecol. 2005 Dec; 193(6):2144-8.
    View in: PubMed
    Score: 0.010
  37. Upadhya B, Applegate RJ, Sane DC, Deliargyris EN, Kutcher MA, Gandhi SK, Baki TT, Call JT, Little WC. Preprocedural white blood cell count and major adverse cardiac events late after percutaneous coronary intervention in saphenous vein grafts. Am J Cardiol. 2005 Aug 15; 96(4):515-8.
    View in: PubMed
    Score: 0.010
  38. Massad MG, Kpodonu J, Lee J, Espat J, Gandhi S, Tevar A, Geha AS. Outcome of coronary artery bypass operations in patients with renal insufficiency with and without renal transplantation. Chest. 2005 Aug; 128(2):855-62.
    View in: PubMed
    Score: 0.010
  39. Upadhya B, Sane DC, Applegate RJ, Kutcher MA, Gandhi SK, Deliargyris EN. Differences in baseline characteristics and in-hospital outcomes in patients with or without prior stroke undergoing percutaneous coronary intervention. J Invasive Cardiol. 2005 May; 17(5):243-7.
    View in: PubMed
    Score: 0.010
  40. Abramov Y, Gandhi S, Goldberg RP, Botros SM, Kwon C, Sand PK. Site-specific rectocele repair compared with standard posterior colporrhaphy. Obstet Gynecol. 2005 Feb; 105(2):314-8.
    View in: PubMed
    Score: 0.009
  41. Deliargyris EN, Upadhya B, Applegate RJ, Kutcher MA, Gandhi SK, Sane DC. Superior in-hospital and 30-day outcomes with abciximab versus eptifibatide: a contemporary analysis of 495 consecutive percutaneous coronary interventions. J Invasive Cardiol. 2004 Nov; 16(11):611-6.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.